NewAmsterdam Pharma Stock Target Price and Analyst Consensus
| NAMSW Stock | 11.29 0.88 8.45% |
Analysts of NewAmsterdam Pharma render investment recommendations by dissecting financials, analyzing earning calls, and talking to NewAmsterdam Pharma vendors, executives, and customers to validate their buy-or-sell advice. Unfortunately, the analyst consensus on NewAmsterdam Pharma is currently unavailable. Please use our comprehensive buy-or-sell advice module to check the latest Macroaxis investment opinion on NewAmsterdam Pharma
Gross Profit is likely to drop to about 13.9 M in 2025. Pretax Profit Margin is likely to climb to -13.72 in 2025. At this time, NewAmsterdam Pharma's Other Current Liabilities is fairly stable compared to the past year. Property Plant And Equipment Net is likely to climb to about 122.9 K in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 51.3 K in 2025. NewAmsterdam |
It's important to approach NewAmsterdam Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize NewAmsterdam Pharma price targets
NewAmsterdam Pharma's stock target price is an estimate of its future price, usually made by analysts. Using NewAmsterdam Pharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at NewAmsterdam Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if NewAmsterdam Pharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional NewAmsterdam Pharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of NewAmsterdam Pharma is a key component of NewAmsterdam Pharma valuation and have some predictive power on the future returns of a NewAmsterdam Pharma.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NewAmsterdam Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | Utilities Invested over 90 shares | |
 | Millennials Best Invested over 90 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 30 shares | |
 | ESG Investing Invested few shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | Chemicals Invested over 30 shares | |
 | Momentum Invested few shares | |
 | FinTech Invested over 30 shares | |
 | Insurance Invested over 200 shares | |
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.